Amneal Pharmaceuticals Overview
Get informed when a big investor buys or sells
+ Follow27.50
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Amneal Pharmaceuticals's peg ratio stands at 27.5. That is above the Healthcare sector average of 12.15. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Amneal Pharmaceuticals sits higher the Healthcare benchmark (12.15) with a PEG ratio of 27.5. That is roughly 126.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 27.5 is attractive depends on Amneal Pharmaceuticals's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Amneal Pharmaceuticals's PEG ratio evolved across reporting periods, while the comparison chart places AMRX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, PEG ratio is commonly used to spot outliers. Amneal Pharmaceuticals's reading of 27.5 (sector avg 12.15) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
